Bernhard Siepen

1 in 4 ICHs are linked to oral anticoagulants 🧠🩸💊

Check out our publication in reviewing current evidence on reversal strategies for VKA-, direct thrombin-, and factor Xa inhibitor-associated ICH.

journals.sagepub.com/doi/10.1177/23…

@DavidSeiffge @StrokeBern @FishingNeurons @ESOstroke

So honoured our planned MAX-ICH pilot study 🧠🩸 received the IAM award 2024 for best research project.

Thanks to @ESOstroke and organisers @Lau_Puy, Andrea Morotti & Thorsten Steiner.

Would not be possible without @davidseiffge @researchbern 🙏🏻

Interested in the comparison of use of andexanet alfa compared to any other non-specific treatment strategy in non-traumatic ICH associated with FXaI?🧠🩸

Check out our poster 2773 at the #WSC2023

@DavidSeiffge
@FishingNeurons
@TotoMynell
@Ash_Shoamanesh
@StrokeBern

First time attending the #WICH2023.

Thanks to @Ash_Shoamanesh, his team and all the speakers for an excellent conference.

Looking forward to #WICH2025 in Sydney.

@StrokeBern

Excellent start by @TotoMynell on thrombolysis for acute ischemic stroke in patients with recent DOAC use at the #WSC2023.

Check out his publication: doi: 10.1001/jamaneurol.2022.4782

@DavidSeiffge
@StrokeBern